Powerful new medications such as Ozempic and Mounjaro, known as GLP-1 drugs are helping to win the war against obesity in ...

Ozempic and Mounjaro are both very popular for weight loss at the minute, but there's one big difference between the two ...

GLP-1 drugs like semaglutide (Ozempic) and tirzepatide (Mounjaro) may shrink fat, but also crucial muscle mass, with little ...

New research shows that most people regain weight after stopping Ozempic and similar weight-loss drugs around the eight-week ...

A new study reports that mice shed about 20% of their body weight and saw their breast cancer tumors decrease after getting ...

Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to ...

Whenever you successfully shed excess weight and arrive at a leaner and healthier version of yourself, the prime concern ...

GoodRx reports that insurance coverage for GLP-1 medications varies. It's more likely when prescribed for FDA-approved uses ...

Some 20 weeks after stopping their drugs, the participants in the studies had put back on an average of 2.5 kilograms (5.5 ...

This new drug is a jab at Ozempic. Tirzepatide, a weekly injectable that rivals celebrity-favorite Wegovy, is one step closer to approval for weight loss by the Food and Drug Administration after ...

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

Several anti-obesity drugs, including Ozempic, Wegovy and Mounjaro, have created buzz in the Indian markets. But are they really approved for use in India? What are their side-effects? And how much do ...